J. Saurat, J. Lachapelle, D. Lipsker, and L. Thomas, Dermatologie et infections sexuellement transmissibles. 5 e éd, 2009.

A. Barbaud, Prise en charge globale des toxidermies, Annales de Dermatologie et de V??n??r??ologie, vol.134, issue.4, pp.391-401, 2007.
DOI : 10.1016/S0151-9638(07)89201-5

S. Martin, A. Barbaud, J. Schmutz, B. Gobert, G. Faure et al., Polyclonal T lymphocyte proliferation in drug lymphocyte activation test, Ann. Dermatol. Venereol, vol.127, pp.268-72, 2000.

H. Peyrière, O. Dereure, H. Breton, P. Demoly, M. Cociglio et al., Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?, British Journal of Dermatology, vol.29, issue.3, pp.422-430, 2006.
DOI : 10.1097/00002030-199905280-00022

M. Eshki, L. Allanore, P. Musette, B. Milpied, A. Grange et al., Twelve-Year Analysis of Severe Cases of Drug Reaction With Eosinophilia and Systemic Symptoms, Archives of Dermatology, vol.145, issue.1, pp.67-72, 2009.
DOI : 10.1001/archderm.145.1.67

S. Walsh and D. Creamer, Drug reaction with eosinophilia and systemic symptoms (DRESS): a clinical update and review of current thinking, Clinical and Experimental Dermatology, vol.115, issue.Suppl. 1, pp.6-11, 2011.
DOI : 10.5414/CNP64155

V. Descamps, B. Saïd, B. Sassolas, B. Truchetet, F. Avenel-audran et al., Prise en charge du drug reaction with eosinophilia and systemic symptoms (DRESS), Annales de Dermatologie et de V??n??r??ologie, vol.137, issue.11, pp.703-711, 2010.
DOI : 10.1016/j.annder.2010.04.024

Y. Teraki and T. Shiohara, IFN-?????producing effector CD8+ T cells and IL-10???producing regulatory CD4+ T cells in fixed drug eruption, Journal of Allergy and Clinical Immunology, vol.112, issue.3, pp.609-624, 2003.
DOI : 10.1016/S0091-6749(03)01624-5

L. French, Toxic Epidermal Necrolysis and Stevens Johnson Syndrome: Our Current Understanding, Allergology International, vol.55, issue.1, pp.9-16, 2006.
DOI : 10.2332/allergolint.55.9

URL : https://doi.org/10.2332/allergolint.55.9

A. Auquier-dunant, M. Mockenhaupt, L. Naldi, O. Correia, W. Schröder et al., Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis, Archives of Dermatology, vol.138, issue.8, pp.1019-1043, 2002.
DOI : 10.1001/archderm.138.8.1019

S. Bastuji-garin, N. Fouchard, M. Bertocchi, J. Roujeau, J. Revuz et al., SCORTEN: a severity-of-illness score for toxic epidermal necrolysis, J. Invest. Dermatol, vol.115, pp.149-53, 2000.

B. Côté, J. Wechsler, S. Bastuji-garin, H. Assier, J. Revuz et al., Clinicopathologic correlation in erythema multiforme and Stevens-Johnson syndrome, Archives of Dermatology, vol.131, issue.11, pp.1268-72, 1995.
DOI : 10.1001/archderm.131.11.1268

H. Assier, S. Bastuji-garin, J. Revuz, and J. Roujeau, Erythema Multiforme With Mucous Membrane Involvement and Stevens-Johnson Syndrome Are Clinically Different Disorders With Distinct Causes, Archives of Dermatology, vol.131, issue.5, pp.539-582, 1995.
DOI : 10.1001/archderm.1995.01690170041005

T. Chave, N. Mortimer, M. Sladden, A. Hall, and P. Hutchinson, Toxic epidermal necrolysis: current evidence, practical management and future directions, British Journal of Dermatology, vol.92, issue.2, pp.241-53, 2005.
DOI : 10.1097/00007611-199909000-00015

C. Paul, P. Wolkenstein, H. Adle, J. Wechsler, H. Garchon et al., Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis, British Journal of Dermatology, vol.91, issue.4, pp.710-714, 1996.
DOI : 10.1016/0167-5699(94)90249-6

C. Beylot, P. Bioulac, and M. Doutre, Acute generalized exanthematic pustuloses (four cases), Ann. Dermatol. Venereol, vol.107, pp.37-48, 1980.

A. Sidoroff, S. Halevy, J. Bavinck, L. Vaillant, and J. Roujeau, Acute generalized exanthematous pustulosis (AGEP) - A clinical reaction pattern, Journal of Cutaneous Pathology, vol.125, issue.3, pp.113-122, 2001.
DOI : 10.1111/j.1365-2133.1991.tb14182.x

M. Speeckaert, R. Speeckaert, J. Lambert, and L. Brochez, Acute generalized exanthematous pustulosis: an overview of the clinical, immunological and diagnostic concepts, Eur. J. Dermatol, vol.20, pp.425-458, 2010.

P. Mckee, E. Calonje, and S. Granter, Cutaneous adverse reactions to drugs. Dans: Pathology of the skin, p.2112, 2005.

D. Gerson, V. Sriganeshan, and A. Jb, Cutaneous drug eruptions: A 5-year experience, Journal of the American Academy of Dermatology, vol.59, issue.6, pp.995-1004, 2008.
DOI : 10.1016/j.jaad.2008.09.015

M. Brönnimann and N. Yawalkar, Histopathology of drug-induced exanthems: is there a role in diagnosis of drug allergy?, Current Opinion in Allergy and Clinical Immunology, vol.5, issue.4, pp.317-338, 2005.
DOI : 10.1097/01.all.0000173787.65777.77

P. Ramdial and D. Naidoo, Drug-induced cutaneous pathology, Journal of Clinical Pathology, vol.62, issue.6, pp.493-504, 2009.
DOI : 10.1136/jcp.2008.058289

H. Justiniano, A. Berlingeri-ramos, and J. Sánchez, Pattern Analysis of Drug-Induced Skin Diseases, The American Journal of Dermatopathology, vol.30, issue.4, pp.352-69, 2008.
DOI : 10.1097/DAD.0b013e3181722ef4

N. Brahimi, E. Routier, N. Raison-peyron, A. Tronquoy, C. Pouget-jasson et al., A three-year-analysis of fixed drug eruptions in hospital settings in France, Eur. J. Dermatol, vol.20, pp.461-465, 2010.

H. Hosaka, S. Ohtoshi, T. Nakada, and M. Iijima, Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: Frozen-section diagnosis, The Journal of Dermatology, vol.56, issue.5, pp.407-419, 2010.
DOI : 10.1111/j.1346-8138.1997.tb02524.x

A. Quinn, K. Brown, B. Bonish, J. Curry, K. Gordon et al., Uncovering Histologic Criteria With Prognostic Significance in Toxic Epidermal Necrolysis, Archives of Dermatology, vol.141, issue.6, pp.683-690, 2005.
DOI : 10.1001/archderm.141.6.683

J. Roujeau, P. Bioulac-sage, C. Bourseau, J. Guillaume, P. Bernard et al., Acute generalized exanthematous pustulosis. Analysis of 63 cases, Archives of Dermatology, vol.127, issue.9, pp.1333-1341, 1991.
DOI : 10.1001/archderm.127.9.1333

S. Kardaun, H. Kuiper, V. Fidler, and M. Jonkman, The histopathological spectrum of acute generalized exanthematous pustulosis (AGEP) and its differentiation from generalized pustular psoriasis, Journal of Cutaneous Pathology, vol.175, issue.12, pp.1220-1229, 2010.
DOI : 10.4049/jimmunol.175.11.7678

S. Halevy, S. Kardaun, B. Davidovici, and J. Wechsler, The spectrum of histopathological features in acute generalized exanthematous pustulosis: a study of 102 cases, British Journal of Dermatology, vol.22, issue.Suppl. 4, pp.1245-52, 2010.
DOI : 10.1016/S0002-9440(10)64486-0

E. Wang, J. Lee, A. Tan, and M. Tang, Fas-ligand staining in non-drug- and drug-induced maculopapular rashes, Journal of Cutaneous Pathology, vol.106, issue.2, pp.196-201, 2011.
DOI : 10.7326/0003-4819-139-8-200310210-00012

A. Barbaud, M. Gonçalo, D. Bruynzeel, and A. Bircher, Guidelines for performing skin tests withdrugs in the investigation of cutaneous adverse drug reactions . Proposed by the Working party of the ESCD for the study of skin testing in investigating cutaneous adverse drug reactions, Contact Dermatitis, vol.29, issue.6, pp.321-329, 2001.
DOI : 10.1034/j.1600-0536.2001.450502.x

J. Waton, P. Tréchot, C. Loss-ayav, J. Schmutz, and A. Barbaud, Negative predictive value of drug skin tests in investigating cutaneous adverse drug reactions, British Journal of Dermatology, vol.49, issue.4, pp.786-94, 2009.
DOI : 10.7326/0003-4819-141-1-200407060-00010

C. Chiou, L. Yang, S. Hung, Y. Chang, T. Kuo et al., Clinicopathlogical features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan, Journal of the European Academy of Dermatology and Venereology, vol.132, issue.9, pp.1044-1053, 2008.
DOI : 10.1038/clpt.1981.154

C. Ang, Y. Wang, E. Yoosuff, and Y. Tay, Retrospective analysis of drug-induced hypersensitivity syndrome: A study of 27 patients, Journal of the American Academy of Dermatology, vol.63, issue.2, pp.219-246, 2010.
DOI : 10.1016/j.jaad.2009.08.050

H. Miyauchi, H. Hosokawa, T. Akaeda, H. Iba, and Y. Asada, T-Cell Subsets in Drug-Induced Toxic Epidermal Necrolysis, Archives of Dermatology, vol.127, issue.6, pp.851-856, 1991.
DOI : 10.1001/archderm.1991.01680050095011

S. Schmid, P. Kuechler, M. Britschgi, U. Steiner, N. Yawalkar et al., Acute Generalized Exanthematous Pustulosis, The American Journal of Pathology, vol.161, issue.6, pp.2079-86, 2002.
DOI : 10.1016/S0002-9440(10)64486-0

H. Choi, J. Ku, M. Kim, H. Kang, S. Cho et al., Possible role of Fas/Fas ligand-mediated apoptosis in the pathogenesis of fixed drug eruption, British Journal of Dermatology, vol.24, issue.3, pp.419-444, 2006.
DOI : 10.1159/000053750

A. Nassif, A. Bensussan, G. Dorothée, F. Mami-chouaib, N. Bachot et al., Drug Specific Cytotoxic T-Cells in the Skin Lesions of a Patient with Toxic Epidermal Necrolysis, Journal of Investigative Dermatology, vol.118, issue.4, pp.728-761, 2002.
DOI : 10.1046/j.1523-1747.2002.01622.x